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Abstract 
The C.  elegans rha-1 gene encodes a conserved helicase with ATP-dependent DEAD/H-
box and double-stranded RNA binding domains.  rha-1 is orthologous to the Drosophila 
maleless gene(MLE), an essential component of the dosage compensation machinery that leads 
to a two-fold increase in transcription of genes located on the single X chromosome of males in 
comparison to the transcription rate of homologous genes located on an X chromosome in  
females.  The human ortholog, RNA helicase A (RHA), unwinds double-stranded DNA and 
RNA in a 3’ to 5’ direction.  RHA is a component of several distinct protein complexes, 
including the RNA-induced silencing complex (RISC), the coding region determinant (CRD)-
mediated complex, mRNP granules, and also associates with BRCA1, CREBbp or SMN1 and 
the RNA polymerase II complex, phosphorylated histones (H2AFX).  RHA affects a number of 
different biological activities, including CRD-mediated mRNA stabilization, RNA splicing, 
translation, and transcription. It also has been discovered that regulation of RHA is disrupted in 
many types of cancers.  The C. elegans rha-1 gene is expressed in the gonad where it localizes to 
the nucleus and the cytoplasm and is required for proper development.  Defects in rha-1 lead to 
germline defects, aberrant expression of genes residing in repetitive transgene arrays, and defects 
in RNAi.    
ABC transporter proteins have also been implicated to play a role in  RNAi in C. elegans.  
Ten  out of the sixty-one ABC transporters are required for efficient RNAi in the germ line; these 
transporters are called ABCRNAi transporters.   All of the ABCRNAi transporter mutants interact 
genetically with rde-2 (a novel protein) and mut-7 (a protein with homology to RnaseD).  One of 
these ABCRNAi transporter genes is haf-6.  The works presented here show that rha-1 mutants 
also interact genetically with haf-6, with rde-2, and with mut-7 with respect to RNAi defects.  By 
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contrast, mutations in rha-1 suppress the transposon mobilization phenotypes observed in haf-6 
mutants.  It is also observed that an unknown mutation is genetically interacting with rha-1 and 
haf-6.  We are currently investigating roles for rha-1 in proper accumulation of haf-6 and other 
ABCRNAi transporter mRNAs in an effort to understand the interrelated functions of these 
proteins in RNAi. 
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Discovery of RNAi 
 Anti-sense RNA has been known to inhibit gene expression since before 1990. This 
ability has identified as co-suppression or post-transcriptional gene silencing in plants [1], and 
quelling in fungus [2]. Initial work in C. elegans was spearheaded by Andrew Fire and Craig 
Mello who found that double stranded RNA (dsRNA) was better at elucidating interference of C. 
elegans genes than anti-sense or sense strands [3]. Their experiments involved injecting unc-22 
RNA sense, anti-sense, or a mixture of the two into C. elegans. Their experiments showed that a 
mixture of sense and anti-sense RNA gave almost two orders of magnitude larger response than 
the individual strands alone. They were also able to show that the RNA only interfered with the 
corresponding sequence of interest and greatly reduced the endogenous mRNA levels. When 
experiments analyzed localization of RNA, it was found that the RNA was not just localized to 
the injection site but that the cells from across the worm would also be responsive to the dsRNA. 
This is referred to as the spreading effect and enables the injected dsRNA to affect many tissues 
throughout the worm. Further investigation also proved that very little RNA was needed to elicit 
this RNAi response [3]. This response, suggests that there is an amplification step in the RNAi 
process that allows only a few dsRNAs to interfere with gene expression. Fire and Mello called 
this sequence specific response to introduced dsRNA, RNA interference (RNAi) [3]. 
Conservation of RNAi 
 The currently accepted hypotheses is that such a strong response has evolved as a defense 
against viruses before the divergence of plants and animals [4]. This defense system was first 
discovered in plants[5] and was later found in nematodes [6], fungi [7], insects (such as 
drosophila [8]), protozoa, and mammals [9]. The RNAi pathway in different organisms seems to 
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be highly conserved and is made up of similar proteins, comparable mechanisms of action, and 
an overall conserved response to dsRNA. Although these mechanisms of action are not fully 
understood, each organism shares a similar response to invading dsRNA.  
Functions of RNAi 
 RNAi is part of a large subset of RNA based responses. Small RNAs and RNAi play a 
large role in many aspects of cell development and regulation. RNAi can be as simple as an 
interaction between mRNA and siRNA resulting in direct cleavage of mRNA before it can be 
translated into protein. It can also regulate gene expression less directly such as through 
chromatin remodeling and histone modifications [10]. RNAi has also been shown to be involved 
in the regulation of mitosis and meiosis, as well as play a role in changing developmental stages 
[11-12].  
 The canonical RNAi mode of regulation usually occurs at the post-transcriptional level 
where dsRNA is cleaved into short 21-23nt siRNAs which leads to direct cleavage of the mRNA 
transcript. In situ hybridization was used to exemplify this in C. elegans by looking at operons 
encoding sequence targeted by injected dsRNAs[13]. These experiments also helped prove that 
the RNAi response was active in both the nucleus and the cytoplasm[13]. 
 Besides direct cleavage of gene targets, RNAi is also involved in nonsense-mediated 
decay (NMD) of mRNA. Transcripts that have point mutations or premature stops upstream of 
introns are targeted for degradation via the NMD pathway. A screen for defects in this pathway 
found seven genes, smg1-7, in C. elegans that are important for a functional pathway. Further 
studies showed that these mutants were also defective in RNAi[14].  
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 Another method of RNAi-mediated gene regulation includes transposon silencing and 
transposon transcription by gene specific methylation of associated nuclesosomes[10]. The 
RNAi process may lead to recruitment of histone deacetylases that can change the methylation 
patterns on nucleosomes resulting in suppression of transposon mobilization by condensing the 
transposon DNA within the genome [15]. 
RNAi Pathway 
 RNAi involves many proteins and there are several different pathways that lead to a 
multitude of outcomes. In most organisms the mechanism is very similar. dsRNA in the 
cytoplasm is recognized and cleaved by Dicer into siRNAs. These small siRNAs are 20-25 
nucleotides in length and have unpaired overhangs on either side. The double stranded siRNAs 
are then separated into guide strands (anti-sense) and sense strands. The guide strand is then 
loaded into the RISC (RNA inducing silencing complex) complex. RISC is made up of many 
different proteins. In each organism and pathway the makeup of RISC is different. Commonly 
the complexes include a protein with double stranded RNA binding motifs to bring in and 
position the RNA; it has an Argonaute protein to line up and position the RNA for cleavage. 
Argonaute proteins bind to siRNAs and guide and help facilitate post-transcriptional gene 
silencing by cleaving mRNA using their endonuclease activity. Once the guide strand is loaded 
into the RISC complex, it acts as a template to help RISC find its complimentary target mRNA. 
Once found, one of the catalytic subunits of RISC, an Argonaut protein, cleaves the 
complementary strand. The cleaved target mRNA can then be degraded by non-sense mediated 
mRNA decay, which is able to recognize the mRNA as aberrant. In some organisms, such as 
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nematodes, the smaller pieces can also be subsequently used in similar pathways leading to 
further processing of the siRNA, resulting in amplification of the RNAi response. 
RNAi response in C. elegans 
 
Figure 1.  In C. elegans when dsRNA is introduced it is processed in the cytoplasm. Rde-4 traffics the 
dsRNA to the Dicer Complex where it is cleaved into siRNAs. Rde-1 takes the guide strand to RISC, 
and the RISC complex begins to assemble. Once assembled it finds its complementary mRNA. When 
found an Argonaute protein in the RISC complex cleaves the mRNA. This pathway leads to the 
down-regulation of mRNA. 
RNAi in C. elegans 
 In C. elegans the RNAi process is initiated by an RNase III-related enzyme called Dicer. 
Dicer cleaves long dsRNA that is then used for gene silencing. Dicer is conserved in flies, plants, 
fungi and mammals[16]. The dsRNA binding protein RDE-4 recognizes foreign dsRNA and 
shuttles it to Dicer. RDE-4 and Dicer, together with a group of other proteins, then form the 
Dicer Complex.  Once the dsRNA is loaded into the Dicer Complex, Dicer cleaves it into the 
small 21-23 nucleotide- long siRNAs[17]. It is thought that RDE-1 then separates the resultant 
siRNAs into sense and anti-sense strands. RDE-1 is classified as an Argonaute protein, and 
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contains a PAZ domain (needed for identification of 3’ overhangs seen in siRNAs) and piwi 
domain (used for associating with piRNAs to aid in the silencing of mobile genetic elements) 
and is one of the many and important catalytic proteins needed for RNAi [18]. The anti-sense 
strands, called guide RNAs, are then shuttled by RDE-1 to the RISC. Within the RISC, the guide 
strand acts as a template to find the complementary target mRNA. Once the target mRNA is 
found, one of the RISC-associated proteins cleaves the mRNA[15, 19]. The now aberrant mRNA 
is then degraded by non-sense mediated mRNA decay, causing the expression of the targeted 
genes to be knocked down (Figure 1).  
 It is believed that RNA-dependent RNA polymerases (RdRPs) use the sense strands and 
the newly cleaved mRNA to produce secondary siRNAs. This would help explain why such 
small amounts of dsRNA are needed to induce complete silencing of a gene. There are four 
RdRps in C. elegans: EGO-1, RRF-1, RRF-2, and RRF-3. Two of these, RRF-3 and EGO-1, are 
needed for the production of secondary siRNAs. It is known that the process uses a different set 
of Argonaute proteins in a similar pathway to that of primary siRNAs.  Two proteins that are also 
believed to be important in the secondary RNAi pathway are MUT-7 and RDE-2. Mut-7 encodes 
an exoribonuclease with 3′ to 5′ exonuclease activity. rde-2 was found when screening for RNAi 
deficiencies, but its exact function is less understood. Both MUT-7 and RDE-2 are involved with 
X-chromosome nondisjunction and transposon mobilization. MUT-7 and RDE-2 are part of a 
complex found in the cytoplasm. When RNAi processing is underway this complex begins to 
grow by recruiting more proteins that are needed for the RNAi process. This complex is not 
necessary for secondary siRNA production but is believed to be required in the pathway between 
primary mRNA target cleavage and prior to secondary siRNA [20]. The primary siRNAs and 
secondary siRNAs can be distinguished from each other by differences at the 5’ ends. Secondary 
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siRNAs have di- or triphosphates and primary siRNAs have monophosphates, which can be 
identified by capping or kinase activity assays[21].
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ABC Transporters  
 ATP-binding cassette transporters (ABC transporters) are part of a large super family of 
proteins that are found in all organisms. These transporters have many functions but are all 
transmembrane proteins that hydrolyze ATP. ABC transporters use the energy from ATP 
hydrolysis to transport a wide range of substrates across membranes. To be classified as an ABC 
transporter the protein must have a transmembrane domain and an ATP-binding cassette domain 
(ABC domain). The transmembrane domain consists of alpha helixes that span the lipid bilayer 
of membranes. This domain gives the transporter its specificity, and the sequences will vary 
depending on what type of substrate the transporter is carrying.  The ABC domain is highly 
conserved and resides on the cytoplasm side of the lipid membrane. This is where ATP binding 
and hydrolysis occur. There are two classes of ABC transporters, full transporters and half 
transporters. Full transporters are made up of at least two transmembrane domains and two ABC 
domains. Half transporters have only one transmembrane domain and one ABC domain. To 
function in the cell these half transporters must find their binding partners to form a complete 
functioning ABC transporter. Half-transporters will dimerize with a different half transporter or 
they will form a homodimer so they can become fully functional.  
 The ABC transporter family is so large and diverse that these transporters are found in 
almost all cell membranes in all organisms. ABC transporters are vital for various physiological 
activities. These transporters function to move a variety of substrates in and out of cells such as 
salts, bile, cholesterol, peptides, lipids, and many other small molecules. They can also act as 
signals, for example by pumping lipid-modified peptides they can direct cell migration[22]. They 
have also been implicated in several types of cancers. Overall Forty-eight ABC genes have been 
found in humans, fourteen of which are thought to be related to cancers such as cystic fibrosis, 
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adrenoleukodystrophy, Stargardt's disease, drug-resistant tumors, Dubin-Johnson syndrome, 
Byler's disease, progressive familiar intrahepatic cholestasis, and X-linked sideroblastic 
anemia[23]. Not only are some of these transporters able to efflux chemotherapeutic drugs but 
they are also upregulated in some types of multi drug resistant cancers[24]. 
ABC Transporters in C. elegans 
C. elegans has sixty-one ABC transporter genes[25-26]. These ABC transporter genes 
play a vital role in the C. elegan’s life cycle. Transporters have also been shown to be required 
for timing in embryonic development[27]. They are known to regulate lysosome biogenesis, part 
of the fat storage pathway in C. elegans(PGP-2)[28], and ABC transporters such as MRP-1 and 
PGP-1 are known to efflux chemotherapeutic drugs from cells[29]. Others such as CED-7 and 
CED-1 are involved in removal of unwanted or harmful cells[30-31]. 
One other important function for ABC transporters is the role they play in RNAi. The 
Timmons lab identified ten transporters required for efficient RNAi[32-33], and has named these 
transporters ABCRNAi transporters  (Figure 3). Of the sixty-one transporters in C. elegans forty-
three mutant transporters were tested for RNAi efficiency and nine were found to be deficient. 
These transporters were then used in tests to see if they would complement mutations in rde-2 
and mut-7. All nine transporters were non-complementary meaning they are genetically linked to 
the rde-2/mut-7 RNAi pathway. The half transporter haf-9 was also added to this list of ABCRNAi 
transporters. On its own it was not defective in the RNAi process, but it did show to be non-
complementary with rde-2 and mut-7[32]. These related transporters are all needed for proper 
RNAi but their expression patterns, protein configurations, and the high homology of all ABC 
transporters does not lend any specific clues to how these transporters are needed for RNAi. 
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RNAi defects in ABCRNAi transporters detected using pop-1 assay 
 
Figure 2. Shows ABCRNAi transporter mutants are defective in RNAi.  When these transporter 
mutants are reared on pop-1 food they show differing degrees of RNAi defects. This figure was 
taken from Sundaram, P., et al.[32].   
 
One of these ABCRNAi transporters is haf-6. This is a half transporter that is localized to 
reticular membranes and can be found in the germ line and intestines[33]. haf-6 has an allele 
(ne335) which was found to be defective in RNAi processing dependant on how the dsRNA was 
delivered. The mutant responded to dsRNA when it was injected into the worms but showed to 
be defective when the dsRNA was introduced through feeding assays[3, 15, 33]. When given 
low amounts of dsRNA the mutants did not have an RNAi response, however when increased 
dosages of dsRNA were delivered there was a strong RNAi response. That is, that the mutational 
effects of defective haf-6 are dosage sensitive, with respect to dsRNA.  These mutants are RNAi 
defective for genes expressed in the germline.[33].
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RNA Helicases  
 RNA Helicase proteins are conserved across many organisms such as viruses, bacteria, 
nematodes, and humans. Usually RNA helicase proteins use ATP hydrolysis to unwind annealed 
RNA, DNA or RNA to DNA strands. It accomplishes this by moving along the nucleic acid 
phosphodiester backbone to separate the annealed strands. RNA helicases have many functions 
within the cell. For example they can displace RNA from protein and can rearrange 
ribonucleoprotein assemblies [34]. RNA helicases that unwind double stranded RNA are 
members of the DEAD box family, or the DExH/D family, named after their conserved sequence 
motif (Asp–Glu–Ala–Asp) [35]. These families of helicases share eight conserved regions that 
are thought to relate to ATP hydrolysis, helicase activity or RNA binding[36]. Although all 
proteins having these conserved sequences are called helicases, it is undetermined whether they 
all have helicase activity.  
In humans, RNA helicase A (RHA) unwinds double-stranded DNA and RNA in a 3’ to 5’ 
direction.  RHA is a component of several distinct protein complexes, including the RNA-
induced silencing complex (RISC), the coding region determinant (CRD)-mediated complex, 
mRNP granules, and also associates with BRCA1, CREBbp or SMN1, the RNA polymerase II 
complex, and phosphorylated histones (H2AFX) [37-40]. RHA affects a number of different 
biological activities, including CRD-mediated mRNA stabilization, RNA splicing, translation, 
and transcription [41]. Regulation of RHA is disrupted in some types of cancers. RHA in 
humans is a member of the nuclear MEF1 complex that contributes to the up-regulation of mdr-1 
gene expression in multidrug-resistant cancer cells. MDR1 is an ABC transporter and is known 
to efflux drugs from cancer cells.  
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RNA Helicase 1 in C. elegans 
 RNA helicase 1 (Rha-1) functions as a chromatin regulator, which helps in 
germline transcriptional silencing in C. elegans. Defects in rha-1 lead to germline defects, 
aberrant expression of genes residing in repetitive transgene arrays in situations where the 
transgene is normally silenced, and defects in RNAi.  Orthologs of Rha-1 are found in mice, 
cows, and show a 60% homology with Drosophila maleless gene MLE and human RHA. 
Drosophila MLE is an essential component of the dosage compensation machinery that leads to 
a two-fold increase in transcription of genes located on the single X chromosome of males in 
comparison to the transcription rate of homologous genes located on an X chromosome in 
females. All of these orthologs share a conserved ATP domain and an RNA binding DEAD box 
domain [42]. 
To study this RNA helicase, the Walstrom lab used the mutation strain rha-1 (tm329). 
This mutation is a 1,059 bp deletion beginning in exon four. Studies show that this mutant strain 
produces a genetic null[43]. These studies showed 1) that the absence of rha-1 at restrictive 
temperatures caused disruption of normal chromatin organization, 2) that rha-1 is recessive, 3) 
that the defects effect both hermaphrodites and males (males showed stronger defects in gamete 
production), 4) and defects in mitotic proliferation (where mitosis begins correctly but cannot be 
maintained) due to histone modifications[43]. 
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I)  Testing for RNAi deficiency by pop-1 feeding assays 
Bacteria that lack RNaseIII can be engineered to express double stranded RNA.  These 
bacteria can then be fed to C. elegans allowing the dsRNA entry into the worm. The worm’s 
natural responses will produce an RNAi response to the dsRNA and target the mRNA of interest 
for down regulation. To prepare the bacteria, HT115 (DE3) cells were transformed with a 
plasmid that contained segments of dsRNA corresponding to the pop-1 transcript. This dsRNA 
will target TCF and LEF1 transcription factors that are needed for proper embryogenisis. The 
transformed bacteria was induced and plated onto small agarose plates that contained 
tetracycline, ampicillin and Isopropyl β-D-1-thiogalactopyranoside (IPTG) [43-45]. One to four 
larval stage 1 (L1) to larval stage 2(L2) worms were placed on these newly transformed bacteria 
plates. As the worms matured they ingested the bacteria and if they had a functional RNAi 
pathway they produced no progeny. If the worms RNAi pathway was disrupted ingestion of the 
dsRNA would not trigger an RNAi response and they would have progeny. 
 Freshly transformed bacteria (less than five days from transformation) were used for each 
experiment. Wild type and RNAi deficient strains were plated at the same time as the 
experimental plates to ensure that the transformation and expression of the double stranded DNA 
was working. The plates were assayed five days after placing the L1/L2 worms. They were 
scored by counting the number of F1 progeny per adult. Many things can affect the effectiveness 
of food, including the age of the transformation, the temperature, and the stage at which the 
worms were placed on the food. As a result only experiments with wild type worms having zero 
progeny were scored.  
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II) Isolating Mutations  
 1215(tm329) was suspected of having additional mutations besides the known rha-1 
mutation. Primers 683 GCCATCCTCTCAGCCTAC and 684 CCACCCACGCTCTTACATG 
were used to determine that the xx1215 stock had the 35 base pair deletion called haf-6 (ne335). 
To determine whether the xx1215 stock had the yy6 mutation crosses were preformed against 
wild-type worms (xx538) to isolate each known mutation individually. xx1215 was crossed to 
wild-type; if the cross was successful ,indicated by the presence of males in the F1 progeny, the 
progeny were moved to a new plate. Then the F2 generation was cloned out by moving one F2 
worm to an individual plate. Once the F2 generation gave rise to F3’s the F2’s were used for 
PCR analysis of the haf-6 gene. Next the F3 generation was tested for the rha-1 mutation 
(tm329) using the primers 942 AAAACGGCGCCATCCACTCC and 943 
CCATCAAAAAGAGTTACGCG. This led to the production of strains with rha-1 mutations 
with no haf-6 deletion and haf-6 mutants with no rha-1 mutation. These new strains, along with 
controls, were placed on pop-1 feeding plates as described in the methods section I.       
  
III) Complementation Tests 
To determine if rha-1 haf-6 yy6 mut-7 and rde-2 are in the same pathway 
complementation tests were performed. Male stocks were made by using a feeding assay where 
bacteria express dsRNA that corresponds to a kinesin gene, when disrupted this leads to 
increased incidences of nondisjunction that leads to the production of males. rde-2 and mut-7 
stocks did not give rise to a sustainable male stock so few tests were done with these strains. The 
males were then crossed to homozygous mutation strains.  From these crosses all of the F1 
progeny were moved to pop-1 food. If the cross was successful the heterozygous F1’s were then 
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moved, in groups of four, to pop-1 plates. The plates were scored five days from the time they 
were originally placed on pop-1 food. The mutations being tested were considered 
complementary if there was 0 to 2.5 F1’s per adult; they were considered noncomplementary 
mutations if they had 2.5 or more F1’s per adult.  Controls were set up by crossing mutations to 
wild-type strains and assaying in the same manner. All controls led to complementation. 
 
IV) Transposon Mobilization Rates 
Transposon mobilization is a measure of chromosome maintenance. Mobilization means 
that the transposon has been removed from where it was and has moved into another region of 
that chromosome. To measure transposon mobilization, mutants were crossed into an unc-22 
strain that harbors a transposon inserted into this gene. This transposon insertion leads to the 
disruption of the unc-22 muscle gene. This gene is needed for regular sigmoid movement, when 
the gene is disrupted the worm twitches as it moves. rha-1 males were crossed to unc-22 
hermaphrodites and the resulting progeny were screened using PCR to check for the haf-6 
deletion and the rha-1 mutation. These new strains were then sent to Dr. Katharine Wolstrom’s 
lab for analysis. They analyzed the strains by counting the number of total worms and the 
number of non-twitching worms. If you divide the non-twitching worms by the total number of 
worms counted and multiply by 100% this number is called percent revertance.  Percent 
revertance is the percentage of worms that have mobilized the transposon out of the unc-22 gene.  
 
V)       Preparing C. elegans genomic DNA  
Large-scale preps were used to make genomic DNA. Plates were made using the standard 
Nematode Growth Medium (NGM) protocol but substituting agarose for the agar [46]. The 
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plates were then seeded with a sequenced E. coli strain, w3110. An equal amount of worms were 
placed on each plate. The worms were then grown at 22°C until the E. coli was almost gone and 
a sufficient number of adult-stage worms were present. M9 Minimal Media (42mM Na2HPO4, 
24mM KH2PO4, 9mM NaCl, 19mM NH4Cl, 1mM MgSO4 , 0.1mM CaCl2 , 2.0% glucose) was 
then used to rinse the worms into a vial where they were allowed to settle. The M9 was then 
removed and replaced with fresh M9. This was done two times to thoroughly wash the worms. 
After the last wash, lysozyme was added at a concentration of 10 mg per milliliter of settled 
worms. The vial was then incubated at room temperature for two hours with shaking. Once the 
incubation cycle was completed, the worms were washed three times with M9 to remove any 
lysed bacteria. Two milliliters of NTE (100 mM NaCl 50 mM Tris-HCl 20 mM EDTA pH7.5), 
100 ul of 10% SDS and 1µl (10mg/ml) proteinase K was added to the settled worm pellet and 
this was incubated for two additional hours at 65°C. 600 ul of phenol: chloroform (1:1) was 
added per milliliter of worm pellet. This solution was then vortexed and centrifuged in a Fisher 
Scientific Marathon 16 KM centrifuge at 15000xG for five minutes. The aqueous phase was then 
moved to a new tube and ethanol extracted. The DNA/RNA pellet was re-suspended in TE and 
RNase A was added to each tube and incubated at 37°C for two hours. The DNA was then added 
to the DNeasy Blood and Tissue Kit (Qiagen). The kit protocol was followed for cleaning the 
DNA and then eluted with water that was buffered with salts to pH 8.0. Concentrations were 
estimated by electrophoresis on a 0.7% agarose gel. The samples were then dried and sent for 
sequencing. 
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VI)      qRT-PCR  
To isolate mRNA from C. elegans, trizol extraction and a Pure Link RNA Mini Kit 
(Ambion) were used. Sixty worms were placed in trizol and vortexed at 4°C for 20 minutes.  
Chloroform was then added and the sample was vortexed again. After sitting for 3 minutes at 
room temperature the sample was centrifuged in a Fisher Scientific Marathon 16 KM centrifuge 
at 15000xG for 15 minutes at 4°C. The aqueous layer was removed and chloroform was again 
added, vortexed, and centrifuged. The aqueous layer was removed and 70% ethanol was added to 
it. This solution was then placed onto the Pure Link column and the manufacture’s procedure for 
RNA purification was followed. The RNA/DNA was eluted from the column with water 
buffered with salts to pH8.0. To remove the DNA from the sample, the DNA-free Kit (Applied 
Biosystems) was used. A nanodrop spectrophotometer was used to estimate the concentration of 
RNA.  
The same amounts of wild-type DNA and mutant DNA were converted into CDNA using 
SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen). The purified cDNA 
was then used for qRT-PCR using Absolute QPCR SYBR Green Mix (Thermo Scientific). The 
qRT-PCR was set up using approximately 2.1 ng of DNA and 5mmol each of forward and 
reverse primer. The samples were then placed in the MJ Research Bio-Rad Real Time PCR 
Opticon Engine for analysis. The PCR procedure had an annealing temperature of 54°C and an 
extension at 72°C. The fluorescence was measured after each of the 39 extensions.  At the end of 
all cycles a melting curve from 40-95°C was prepared for each well to ensure specific product 
formation.  
 qRT-PCR primers were designed to flank introns to ensure only mRNA was being 
amplified. They were designed to produce short 85-208 base pair products. Two genes were 
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chosen to act as controls: cdc-42 and tba-1. These genes are known to be evenly expressed 
throughout the lifetime of the worm. Primers were designed to walk along the transcript of the 
haf-6 and smg-2 genes while mrp-1 primers were designed to check for several different 
isoforms of Mrp-1. The primers were as follows: 
Primer Number         Sequence                              Region 
1088 AAAGCGCCGTGCAAAGCAGCAAA haf-6 (exon 1)  
1089 GCTCCAAACCCACAAATTCGCCAT haf-6  (exon 2)   
1090 ATGCGGTCGGACTTGTTTCAGAAG haf-6 (exon 3)  
1091 CTGGCTAACGCAGAGCTTGAATGA haf-6 (exon 4) 
1092 TGCAACGTCAGTCGAGGAGAACAT haf-6 (exon 7)  
1093 ATCCACTCGGAAACCTGGACACAA haf-6 (exon 8) 
1094 TATTGGGAACACGCAGGACTCTCA smg-2 (exon 1) 
1095 CCACGTCGTGAAATGGCAAATCGT smg-2 (exon 2) 
1096 AAACACGTTGCTCGGGAACTCTGA smg-2 (exon 5) 
1097 TGTGCTTCTCGGTATTCGACCGTT smg-2 (exon 4) 
1098 AGAATGTGCCCATCCCAGCACATA smg-2 (exon 8) 
1099 ATCCATTGCTGCTTCAGCTTGTGG smg-2 (exon 9) 
1100 TCCCGTTAGTTCGTGAACTGGTGT mrp-1 (exon 1) mrp-1 a,b,c,d3,e 
1101 GCTGGCCACAATTTGTTACTTGCG mrp-1 (exon 2) 
1102 AGATGGTCAGACGATGCCAAGGAA mrp-1 (exon 11) mrp-1 a,b,c,d3,e 
1103 TGATGATTGACGCAGCACAAACGG mrp-1 (exon 12) 
1104 ATATGGACGTGGTGGATGAGCGTT mrp-1 (exon 13) mrp-1 e 
1105 AACGCTTCAATTGCCGAGAAGTGC mrp-1 (exon 14)  
1106 TGTTTATCCGGACTGCCGTATCGT mrp-1 (exon 13) mrp-1a,d3    
1107 TTGTTGGAGCCATCGTTCAAGCTG mrp-1 (exon 13) mrp-1b,d2  
1108 TGATTATTTGGGCAACTCCGTGGG mrp-1 (exon 13) mrp-1c  
1109 TGCATGCCATGGGTGCTTACAA mrp-1 (exon 13) mrp-1d.1  
1110 CGATGCTGAGACTCTCTGATGAA mrp-1 (exon 13)  mrp-1d.1  
1111 CTTGTTTGCTTCTCCGTGGTTGCT cdc-42 
1112 TCTCCAACATCCGTTGACACTGGT cdc-42 
1113 AGCTTGCTCGATCTTCTCATCGGA eIF-3.c  
1114 AGCCAACTCTCCGTCCAATCTTTG eIF-3.c  
1115 ATTGGCTGCGTACACTCCACTGAT tba-1 
1116 ATCGCACTTCACCATTTGGTTGGC tba-1 
 
 
 
22 
 
 
 
 
 
 
 
Chapter V Results and Discussion 
 
23 
 
 haf-6 deletion as a background mutation 
Studies done by the Timmons lab have shown that Haf-6 is an ABCRNAi transporter and 
plays an important role in the RNAi pathway. During regular maintenance of stocks, a strain that 
had a mutation other than haf-6(ne335) was used as a control for a haf-6 PCR reaction.  The 
results of this PCR showed that the strain had the haf-6 35bp deletion. Further studies of 
different mutation strains from different labs showed that the haf-6(ne335) deletion could be 
found in the background of many previously unidentified strains. Table 1 shows some of the 
strains that were tested and contained the haf-6(ne335) deletion. Some of the strains were then 
crossed to wild-type worms so that they contained only single mutations. Interestingly, several of 
these mutant strains were shown in the literature to have no defects in the RNAi pathway.  This 
is contradictory to the hypothesis that haf-6 is vital for a functional RNAi pathway. 
 To further investigate the role of haf-6, pop-1 feeding assays were used to identify 
defects in the RNAi pathway. pop-1 feeding assays are based on plasmid-expressing bacteria that 
are used as a food source for C. elegans. This plasmid expresses a dsRNA of the C. elegans pop-
1 gene which is needed for embryonic development. If the RNAi pathway is intact then the 
dsRNA is processed and down regulates pop-1. If the worms have an intact RNAi pathway they 
will have no viable progeny, if they are defective they will have progeny. The results showed 
that many of the mutant strains unsuspectingly carrying the haf-6 deletion had a functional RNAi 
pathway (Table 1). Contradictory to this, the haf-6(ne335) mutation has been thoroughly studied 
and it has been shown that it is defective in RNAi. These results lead us to the conclusion that 
some strains contain a third mutation that is suppressing the haf-6 phenotype. This unknown 
mutation has been labeled yy6. The only way to discern if yy6 is present in a strain is to check for 
the haf-6 deletion and to test for RNAi activity. If the strain has both we assume that the yy6 
mutation is present. Studies have shown that this new mutation, yy6, is an intergenic mutation.  
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Table 1.  haf-6 deletion is found in several stocks 
 
Table 1: The haf-6 deletion can be found in the background of many different mutation strains from 
many different labs. yy6 is also found in most instances that the haf-6 deletion is seen. (+) stands for 
wild type, (--) means defective and (+/--) means slightly defective with respect to RNAi activity. 
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Mapping yy6 
Mapping of yy6 showed that it was on chromosome 1 along with the haf-6 gene. This is 
consistent with the observation that the yy6 mutation is always inherited with the haf-6 mutation. 
Mapping yy6 to a smaller region proved to be unsuccessful, so it was decided to send this newly 
discovered triple mutant strain, 1215(tm329), for sequencing. Along with this strain several 
others were sent for sequencing, a xx538 wild-type, xx1683haf-6 yy6 him-5 and xx195 haf-6. 
The libraries have been made and data has been obtained but it is still undergoing analysis. 
Knowing the nature of the yy6 mutation could greatly help in discovering how it is interacting 
with an ABCRNAi transporter and an RNA helicase in the RNAi pathway.  
1215(tm329) is a triple mutant 
Mutation strain KMW1 (1215(tm329)) was thoroughly studied by the Walstrom lab. This 
strain was screened for the haf-6 (ne335) deletion by the Timmons lab and it harbored the 
deletion. As well as being RNAi defective, rha-1 mutations have defects in gamete production 
and chromosomal regulation. To see if this strain also contained the third mutation (yy6), the 
strain was crossed with a wild-type worm and the mutants were isolated. Previous studies have 
shown that yy6 is close to haf-6 so they are inherited together. Once the mutants were isolated 
and confirmed by PCR, pop-1 feeding assays were used to identify RNAi defects (figure 3). 
These tests showed that the haf-6 strain isolated from 1215(tm329) was not RNAi defective. This 
leads us to conclude that this strain must contain the mutation yy6. The rha-1 mutation that was 
isolated from 1215(tm329) was found to be only slightly RNAi defective. This result can be 
compared to the xx953 (tm329) strain that was made by out-crossing 1215(tm329) to wild-type 
worms. Interestingly the triple mutant was strongly defective in RNAi processing but when the 
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rha-1 mutation is isolated it is only weakly defective and the haf-6, yy6 strain is not defective at 
all.  Further studies need to be done to see if all of the phenotypes previously seen in 
1215(tm329) are still present in the absence of the haf-6 and yy6 mutations and to find out how 
this third rha-1 mutation is interacting with the haf-6 yy6 mutations and suppressing their 
phenotype. 
                  RNAi defects detected using pop-1 feeding assay 
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Figure 3.  pop-1 feeding assay to look for RNAi defects in different mutant backgrounds. Wild-type 
worms show no RNAi defects so they produce no progeny.  haf-6 mutants show strong defects in 
RNAi. rha-1 (tm329) is a strain that has been out-crossed and contains only the rha-1 mutation. The 
next two strains were isolated from 1215(tm329). The rha-1 mutation that was isolated from the 
triple mutant strain shows the same deficiencies in RNAi. The haf-6 mutation that was isolated from 
the triple mutants shows almost no defects in the RNAi pathway, which leads us to believe that it 
contains the yy6 mutation. Next is a haf-6 strain that has the yy6 mutation and serves as a control. 
The triple mutant shows the strongest RNAi defects. 
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Genetic interactions 
The next experiment was designed to see genetic interactions between rha-1  haf-6 and 
yy6. ABCRNAi transporters are known to genetically interact in the             Mut-7 / Rde-2 
pathway. rha-1 is interacting with the ABCRNAi transporter haf-6 and has been shown to interact 
with mut-7 and rde-2 but that was before the haf-6 was discovered to be in the background of 
this strain. To ensure that this interaction was due to the rha-1 mutation and not because of the 
haf-6 mutation we set up complementation tests to look for genetic interactions. The resulting F1 
progeny were then analyzed for RNAi defects. The results of these experiments can be seen in 
Table 2. The data reveal a genetic interaction between all of the mutants, because each mutant 
shows non-complementation with the other mutants. This table represents cross progeny, which 
means each box represents an F1 progeny that has inherited half of its genes from each parent.  
Table 2 shows that all of the mutants are non-complementary to mut-7 and rde-2 meaning that 
they genetically interact in this pathway. The data also show that; 1) haf-6 genetically interacts 
with rha-1, 2) yy6 changes the interaction with haf-6 and rha-1 so that it is now complementary 
and the RNAi pathway is working correctly, 3) there is a paternal effect seen between haf-6 and 
rha-1 (when the rha-1 mutation comes from the hermaphrodite there is a stronger deficiency in 
the RNAi process), and 4) yy6 acts recessively, but rha-1 must be homozygous to change the 
interaction between haf-6 and yy6. The data suggest that haf-6 rha-1 and yy6 interact with mut-
7/rde-2 and all are genetically interacting with each other. 
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Table 2.  RNAi defects seen in complementation progeny 
 
Complementation tests were set up using different combinations of mutations and then the 
heterozygous F1 progeny were moved to pop-1 food to look for RNAi defects. All mutations are non-
complementary with mut-7 and rde-2 suggesting that all of these mutations are in the same pathway. 
This chart shows that rha-1 may have stronger maternal effects than haf-6. When rha-1 is 
homozygous you can see its interaction on the RNAi pathway but when heterozygous RNAi activity is 
not affected by rha-1. Crosses also reveal that even when yy6 is heterozygous it still is affecting the 
RNAi pathway.  
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Transposon mobilization 
 haf-6 has been shown to be a mutator gene which can lead to an increased incidence of 
transposon mobilization, as well as having a role in chromosome regulation. To examine 
transposon mobilization rates, mutant strains were crossed with unc-22 twitchers. unc-22 worms 
twitch due to a transposon inserted into the unc-22 muscle gene. Revertance can be measured by 
counting the number of non-twitching worms, where the transposon has hopped out of the 
muscle gene. This gives a measure of chromatin regulation. The results shown in Table 3 
indicate that there is an increased amount of transposon mobilization in haf-6 mutants at 
restrictive temperatures. The pop-1 feeding assay showed that yy6 and rha-1 rescue the defects 
caused by the haf-6 deletion. This rescue can also be seen in the revertant percentages, which are 
back to 0% in the unc-22 haf-6 yy6 mutants meaning that transposon mobilization is not 
occurring. When the rha-1 mutation is added to this background we do not see a change in 
phenotype. In the pop-1 feeding assays we saw that rha-1 was effecting the yy6 haf-6 interaction. 
In this mutator assay we see that the rha-1 mutation is having no effect on transposon 
mobilization phenotypes of haf-6 yy6 genes.  This different outcome leads us to believe that this 
could be a very germline specific response.  pop-1 feeding assays are based on a continuous 
feeding of dsRNA against a germline protein that is required for proper development of gametes.  
Both Haf-6 and Rha-1 have been shown to be expressed in the germline and help with regulation 
of germline proteins. Unc-22 is a muscle protein and might be under different chromosomal 
regulation than germline genes. 
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Table 3.  Transposon Mobilization 
 
unc-22 was crossed into haf-6 rha-1 and yy6 mutants. Revertants was then measured by counting non-
twitching worms out of total worms. The yy6 mutation rescues the transposon mobilization phenotype seen in 
haf-6 mutants but rha-1 has no effect on the yy6 haf-6 interactions in this assay.   
 
Protein expression levels 
haf-6 and smg-2 are neighboring genes on chromosome one. These two genes are 
transcribed in opposite directions from a shared promoter region (Figure 4). smg-2 phenotypes 
are sometimes seen in haf-6 mutants; these include phenotypes such as the males going sterile 
and hermaphrodites having protruding vulvas. Previous work has been done that showed haf-6 
mutants are rescued by haf-6 cDNA but not by smg-2 cDNA. The reverse has shown that smg-2 
mutants are only rescued by smg-2 cDNA. It is known that some transcription elements for haf-6 
are in the smg-2 gene. This lead us to the question that if smg-2 contains haf-6 regulatory 
elements does haf-6 contain smg-2 regulatory elements that could be affected by the haf-6 35bp 
deletion.  
To test this we used quantitative reverse transcriptase PCR (qRT-PCR) to look at 
expression levels of smg-2 mRNA in wild-type worms and in haf-6 mutant worms. Figure 5 
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shows the results of two independent experiments using two different sets of haf-6 and wild-type 
cDNA. Two genes, cdc-42 and tba-1, were used as loading controls to ensure equal amounts of 
DNA were loaded into each reaction. Both experiments show that when you compare haf-6 
mutant cDNA to wild-type CDNA and adjust for concentration by cdc-42 or tba-1 that the 
expression levels of smg-2 does not significantly differ between the two strains. haf-6 primers 
were used to show that haf-6 mRNA expression levels are significantly decreased when haf-6 
mutant cDNA  is compared to wild-type cDNA.  This is as expected because the 35bp deletion 
shifts transcription out of frame and leads to a nonfunctional protein. 
 
                                    Gene map of smg-2 and haf-6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Gene map of smg-2 and haf-6. The red square represents the shared 800bp promoter 
region. The dark arrows indicate the direction of transcription. The small arrow is pointing to 
exon three where there is a 35bp deletion in haf-6 mutants.  
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Figure 5. Graph showing that smg-2 expression levels are not affected in a haf-6 mutant 
background. A and B are duplicate experiments using different isolated sets of haf-6 and 
wild-type cDNA. 
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Chapter VI  Summary of Significance  
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The work in the Timmons lab on ABC transporters and their function in the RNAi 
pathway was the starting point for these projects. The discovery that the haf-6(ne335) mutation 
could be unsuspectingly found in many strains that have properly functioning RNAi led us to 
discover these interacting genes. Screens for strains carrying the haf-6(ne335) directed us to the 
very interesting mutant  rha-1 strain. Dr, Katherine Wolstrom had characterized this mutant in 
detail and found that these mutants have reduced germ cell meiosis, defective mitosis, 
temperature-sensitive sterility, and that it genetically interacts in the mut-7/rde-2 pathway. When 
these studies were done it was not know that haf-6(ne335) was in the background. This list of 
phenotypes can also describe haf-6 mutants. Our studies were focused on these mutations and 
how they are interacting in the RNAi pathway.  
pop-1 feeding assays are an effective and reliable way to see if  RNAi processing is 
occurring properly. These assays revealed that a second mutation must be accompanying the 
(haf-6 ne335) deletion when found in strains that have a functioning RNAi pathway. The 
discovery of yy6 and its ability to rescue the defects in RNAi and transposon mobilization in 
haf-6 strains leaves many questions.  The identification of another gene that can directly interact 
with these two mutations in an RNAi dependent maner but not in transposnon mobilization 
shows how many different and parallel pathways need the same proteins. Mutant rha-1 strains 
are weakly RNAi defective but with the haf-6 and yy6 mutations added the defects in RNAi are 
significantly stronger. Many studies need to be done to see how an RNA helicase protein, an 
ABC transporter and this newly discovered mutation are acting in conjunction in the RNA 
pathway. Identification of the substrate that haf-6 is transporting in the ER could lead to a greater 
understanding of its role in RNAi. In humans RhaA has been to associate in the cytoplasm in the 
RISC complex, but this has not been discovered yet in C. elegans. RhaA has many functions 
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within the cell more studies need to be done to see how rha-1 shares these very diverse 
functions. 
Transposons are mobile genetic elements that play a major but silent role in most 
eukaryotic organisms. These elements make up a significant fraction of the genome. A piece of 
DNA that has the ability to move from position to position along a chromosome can have 
devastating effects on its host cell. Transposons provide a way for genetic diversity but insertion 
of a transposable element into a gene can also cause mutations. This mutagenic activity can lead 
to disease. ABC transporters and RNA helicases in cancer show an increased rate of transposon 
mobilization. RNAi is one mechanism that is believed to regulate these transposable elements. 
Transposon mobilization assays allow us to see if these RNAi deficient mutants are also involved 
in this chromosomal specific pathway. haf-6 and yy6 seem to function in the regulation of 
chromosomes as seen by the haf-6 mutants inability to keep its transposon silenced and yy6s 
ability to rescue this defect. The fact that rha-1 does not show a defect in properly maintaining 
its transposable elements leads us to believe that its function in the RNAi pathway might reside 
outside of the nucleuses.  
The appearance of smg-2 phenotypes in haf-6 strains led us to question whether the smg-
2 genes were being affected by the deletion in haf-6 mutants. smg-2 phenotypes include 
protruding vulvas and male sterility, both which are seen in haf-6 strains under working lab 
condition. These two genes share a common 800 bp promoter region and it is known that the 
smg-2 gene contains regulatory elements that effect haf-6 transcription. The appearance of these 
phenotypes and the fact that they share a promoter region lead us to see if expression levels of 
smg-2 were affected in a haf-6 background. qRT-PCR studies showed that smg-2 expression 
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levels are not  changed in haf-6 mutants. These experiments were done under normal working 
conditions.  Further studies need to be completed to ensure that environmental conditions will 
not change these expression rates.  
Human RhaA (ortholog of C. elegans rha-1) is present in the MEF transcription factor 
complex. In cancer cells RhaA up-regulates the expression of MDR1 (multidrug resistannce gene 
1) which is an ABC transporter. MDR1s function in the cell is to remove a wide variety of drugs 
and xenobiotics. The need for this natural defence againt possibly toxic agents is important but in 
cancer cells the up-regulation of this gene leads to efflux of drugs that are required to treat cancer 
cells. C. elegans ortholog to MDR1 is mrp-1-mrp-4 (multidrug resistance protein 1-4). In C. 
elegans mrp-1 is needed for proper RNAi and functions to help remove heavy metals from cells. 
Our preliminary results (data not shown) indicate that mrp-1 mRNA levels are not affected in a 
rha-1 mutant background.  This data does not prove that rha-1 is not affecting mrp-1 levels, but 
leads us to believe that other mechanisms might help in the regulation of mrp-1. More studies 
need to be done to see if by stressing the cells in such a way to mimic cancer in C. elegans might 
alter the expression levels of not only mrp-1 but the other three mrp genes. 
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